Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting Journal Article


Authors: Boule, L. A.; Ju, C.; Agudelo, M.; Parira, T.; Cannon, A.; Davis, B; Eby, J.; Cresci, G.; Samuelson, D. R.; Shukla, P.; Alrefai, W. A.; Sureshchandra, S.; Pandey, S. C.; Schnabl, B.; Curtis, B. J.; Wyatt, T. A.; Choudhry, M. A.; Kovacs, E. J.
Article Title: Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting
Abstract: On November 18, 2016 the 21st annual Alcohol and Immunology Research Interest Group (AIRIG) meeting was held at the Center for Translational Research and Education at Loyola University Chicago#39;s Health Sciences Campus in Maywood, IL. The 2016 meeting focused broadly on alcohol and inflammation, epigenetics, and the microbiome. The four plenary sessions of the meeting were Alcohol, Inflammation, and Immunity; Alcohol and Epigenetics; Alcohol, Transcriptional Regulation, and Epigenetics; and Alcohol, Intestinal Mucosa, and the Gut Microbiome. Presentations in all sessions of the meeting explored putative underlying causes for chronic diseases and mortality associated with alcohol consumption, shedding light on future work and potential therapeutic targets to alleviate the negative effects of alcohol misuse.
Journal Title: Alcohol (Fayetteville, N.Y.)
Volume: 66
ISSN: 1873-6823; 0741-8329
Publisher: Unknown  
Journal Place: United States
Date Published: 2018
Start Page: 35
End Page: 43
Language: eng
DOI/URL:
Notes: LR: 20180329; CI: Copyright (c) 2017; GR: R01 AA020703/AA/NIAAA NIH HHS/United States; GR: P60 AA009803/AA/NIAAA NIH HHS/United States; GR: U01 AA013510/AA/NIAAA NIH HHS/United States; GR: R01 DK071596/DK/NIDDK NIH HHS/United States; GR: R21 AA022387/AA/NIAAA NIH HHS/United States; GR: U01 AA019971/AA/NIAAA NIH HHS/United States; GR: R01 DK109709/DK/NIDDK NIH HHS/United States; GR: T32 AA013527/AA/NIAAA NIH HHS/United States; GR: IK6 BX003781/BX/BLRD VA/United States; GR: UL1 RR025780/RR/NCRR NIH HHS/United States; GR: R01 AA010005/AA/NIAAA NIH HHS/United States; GR: R21 AA022324/AA/NIAAA NIH HHS/United States; GR: U54 GM104940/GM/NIGMS NIH HHS/United States; GR: U01 AA021856/AA/NIAAA NIH HHS/United States; GR: R21 AA021947/AA/NIAAA NIH HHS/United States; GR: R13 AA020768/AA/NIAAA NIH HHS/United States; GR: U01 AA024726/AA/NIAAA NIH HHS/United States; GR: R01 AG018859/AG/NIA NIH HHS/United States; GR: R01 GM115257/GM/NIGMS NIH HHS/United States; GR: R24 AA019431/AA/NIAAA NIH HHS/United States; GR: R01 AA023417/AA/NIAAA NIH HHS/United States; GR: R24 AA019661/AA/NIAAA NIH HHS/United States; GR: R01 AA015731/AA/NIAAA NIH HHS/United States; GR: P50 AA022538/AA/NIAAA NIH HHS/United States; GR: UL1 TR001082/TR/NCATS NIH HHS/United States; GR: I01 BX002213/BX/BLRD VA/United States; GR: I01 BX003635/BX/BLRD VA/United States; GR: R00 AA021264/AA/NIAAA NIH HHS/United States; GR: U01 AA021723/AA/NIAAA NIH HHS/United States; GR: T32 AG000279/AG/NIA NIH HHS/United States; GR: R01 AA020216/AA/NIAAA NIH HHS/United States; GR: R21 AA023193/AA/NIAAA NIH HHS/United States; GR: K99 AA023266/AA/NIAAA NIH HHS/United States; JID: 8502311; NIHMS919107; OTO: NOTNLM; PMCR: 2019/02/01 00:00; 2017/06/27 00:00 [received]; 2017/07/21 00:00 [accepted]; 2019/02/01 00:00 [pmc-release]; 2017/11/12 06:00 [pubmed]; 2017/11/12 06:00 [medline]; 2017/11/12 06:00 [entrez]; ppublish